US5833975A
(en)
*
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
US7045313B1
(en)
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
US5965138A
(en)
*
|
1985-09-06 |
1999-10-12 |
Syntro Corporation |
Recombinant chimeric virus and uses thereof
|
US5961982A
(en)
*
|
1985-09-06 |
1999-10-05 |
Syntro Corporation |
Recombinant herpesvirus of turkeys and uses thereof
|
US5928648A
(en)
*
|
1985-09-06 |
1999-07-27 |
Syntro Corporation |
Recombinant herpesvirus of turkeys and uses thereof
|
MY109299A
(en)
*
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
BR9106879A
(pt)
*
|
1990-09-25 |
1993-07-20 |
Cantab Pharma Res |
Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante
|
US7374768B1
(en)
*
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
US6309647B1
(en)
*
|
1999-07-15 |
2001-10-30 |
Aventis Pasteur |
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
|
US5766597A
(en)
*
|
1991-03-07 |
1998-06-16 |
Virogenetics Corporation |
Malaria recombinant poxviruses
|
US5843456A
(en)
*
|
1991-03-07 |
1998-12-01 |
Virogenetics Corporation |
Alvac poxvirus-rabies compositions and combination compositions and uses
|
KR100242671B1
(ko)
*
|
1991-03-07 |
2000-03-02 |
고돈 에릭 |
유전학적으로 처리한 백신 균주
|
US5997878A
(en)
*
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
AU672581B2
(en)
*
|
1991-03-07 |
1996-10-10 |
Virogenetics Corporation |
Immunodeficiency virus recombinant poxvirus vaccine
|
US5989561A
(en)
*
|
1991-03-07 |
1999-11-23 |
Virogenetics Corporation |
Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
|
US5863542A
(en)
*
|
1991-03-07 |
1999-01-26 |
Virogenetics Corporation |
Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
|
WO1992016616A1
(en)
*
|
1991-03-20 |
1992-10-01 |
Virogenetics Corporation |
Malaria recombinant poxvirus vaccine
|
DE69229390T2
(de)
|
1991-08-26 |
1999-11-11 |
Immuno Ag, Wien |
Direkt molekuläre Klonierung eines modifizierten Genoms eines Chordopocken-Virus
|
US5853733A
(en)
*
|
1993-02-26 |
1998-12-29 |
Syntro Corporation |
Recombinant herpesvirus of turkeys and uses thereof
|
US6010703A
(en)
*
|
1993-07-26 |
2000-01-04 |
Board Of Trustees Operating Michigan State University |
Recombinant poxvirus vaccine against feline rhinotracheitis
|
DK0758397T3
(da)
*
|
1994-04-29 |
2005-10-10 |
Baxter Healthcare Sa |
Rekombinante poxvira med fremmede polynucleotider i essentielle regioner
|
GB9413035D0
(en)
*
|
1994-06-29 |
1994-08-17 |
Scras |
Antisense oligonucleeotides
|
US5656427A
(en)
*
|
1994-08-29 |
1997-08-12 |
Gen-Probe Incorporated |
Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid
|
FR2737500B1
(fr)
*
|
1995-08-03 |
1997-08-29 |
Bio Merieux |
Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
|
US6060457A
(en)
*
|
1996-06-20 |
2000-05-09 |
Universite De Montreal |
DNA plasmid vaccine for immunization of animals against BVDV
|
EP0979101B1
(de)
|
1996-07-03 |
2010-10-27 |
Merial, Inc. |
Rekombinanter hunde-adenovirus 2 (cav2), welcher exogene dna enthält
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
FR2751227B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
EP0951555A2
(de)
*
|
1996-09-24 |
1999-10-27 |
Bavarian Nordic Research Institute A/S |
Rekombinantes mva-virus das dengue-virus antigene exprimiert und dessen verwendung in impfstoffen
|
US7255862B1
(en)
*
|
1996-11-14 |
2007-08-14 |
Connaught Technology Corporation |
ALVAC/FIV constructs
|
US6004777A
(en)
*
|
1997-03-12 |
1999-12-21 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
US6020319A
(en)
*
|
1997-07-24 |
2000-02-01 |
New York Blood Center |
Nucleic acid based immunotherapy of chronic hepatitis B infection
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6872518B2
(en)
*
|
1997-09-22 |
2005-03-29 |
University Of Rochester |
Methods for selecting polynucleotides encoding T cell epitopes
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
US6224882B1
(en)
|
1997-11-07 |
2001-05-01 |
Protein Science Corp. |
Insect cells or fractions as adjuvant for antigens
|
FR2772047B1
(fr)
*
|
1997-12-05 |
2004-04-09 |
Ct Nat D Etudes Veterinaires E |
Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
|
AT406376B
(de)
*
|
1998-01-16 |
2000-04-25 |
Immuno Ag |
Chimäres poxvirus enthaltend eine retrovirale vektorkomponente
|
JP4741074B2
(ja)
|
1998-02-24 |
2011-08-03 |
シスターズ オブ プロビデンス イン オレゴン |
Ox−40レセプター結合因子又はそれをコードする核酸を含む組成物並びに抗原特異的免疫応答を増強するための方法
|
MXPA00008352A
(es)
*
|
1998-02-27 |
2002-10-17 |
Univ Pennsylvania |
Vacunas, composiciones inmunoterapeuticas y metodos para usar las mismas.
|
WO1999055910A1
(en)
*
|
1998-04-24 |
1999-11-04 |
Arizona Board Of Regents |
Method of inducing apoptosis in a target cell
|
WO1999063064A1
(en)
*
|
1998-06-03 |
1999-12-09 |
American Cyanamid Company |
Novel methods for rescue of rna viruses
|
US20050063950A1
(en)
*
|
1998-11-19 |
2005-03-24 |
Georgetown University |
Systemic viral/ligand gene delivery system and gene therapy
|
ATE483816T1
(de)
|
1998-11-19 |
2010-10-15 |
Univ Georgetown |
Systemisches virus/ligand genabgabemittel und gentherapie
|
US6344337B1
(en)
|
1999-02-19 |
2002-02-05 |
Board Of Trustees Of Michigan State University |
Antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
AU5446700A
(en)
|
1999-05-28 |
2000-12-18 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
|
US6497883B1
(en)
*
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
US6355246B1
(en)
|
1999-06-10 |
2002-03-12 |
Board Of Trustees Of Michigan State University |
Feline calicivirus isolated from cat urine and vaccines thereof
|
AU7108700A
(en)
|
1999-09-02 |
2001-03-26 |
Michigan State University |
Vaccine to control equine protozoal myeloencephalitis in horses
|
US7419668B1
(en)
|
1999-09-02 |
2008-09-02 |
Board Of Trustees Of Michigan State University |
Vaccine to control equine protozoal myeloencephalitis in horses
|
ATE391726T1
(de)
|
1999-10-22 |
2008-04-15 |
Sanofi Pasteur Ltd |
Modifiziertes gp100 und dessen verwendung
|
ES2170622B1
(es)
*
|
1999-12-03 |
2004-05-16 |
Consejo Superior De Investigaciones Cientificas |
Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
|
NZ519655A
(en)
*
|
1999-12-21 |
2004-04-30 |
Merial Sas |
Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
|
US20040009185A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Peter Emtage |
Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen
|
EP2388015A1
(de)
|
2000-03-02 |
2011-11-23 |
Emory University |
DNA-Expressionsvektoren und Verwendungsverfahren
|
US20040105871A1
(en)
*
|
2000-03-02 |
2004-06-03 |
Robinson Harriet L. |
Compositions and methods for generating an immune response
|
US8623379B2
(en)
*
|
2000-03-02 |
2014-01-07 |
Emory University |
Compositions and methods for generating an immune response
|
US20030194696A1
(en)
*
|
2000-03-28 |
2003-10-16 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides of interest
|
WO2001072995A2
(en)
*
|
2000-03-28 |
2001-10-04 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucletides
|
WO2001085932A2
(en)
|
2000-05-10 |
2001-11-15 |
Aventis Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
JP2003533989A
(ja)
*
|
2000-05-24 |
2003-11-18 |
メリアル |
ブタ生殖・呼吸症候群ウィルス(prrsv)の組換えポックスウィルスワクチン
|
US7445924B2
(en)
*
|
2000-11-23 |
2008-11-04 |
Bavarian Nordic A/S |
Modified Vaccinia Ankara virus variant and cultivation method
|
AU2002231639B2
(en)
*
|
2000-11-23 |
2007-01-04 |
Bavarian Nordic A/S |
Modified vaccinia ankara virus variant
|
US20020108132A1
(en)
*
|
2001-02-02 |
2002-08-08 |
Avigenics Inc. |
Production of a monoclonal antibody by a transgenic chicken
|
US20030049651A1
(en)
*
|
2001-03-05 |
2003-03-13 |
Mount Sinai Hospital |
Tumor associated proteins
|
DK1372710T3
(da)
*
|
2001-03-08 |
2010-01-18 |
Us Gov Health & Human Serv |
MVA der udtrykker modificeret HIV-kappe-, Gag- og Pol-gener
|
US7176300B2
(en)
*
|
2001-03-30 |
2007-02-13 |
Avigenics, Inc. |
Avian lysozyme promoter
|
US7202354B2
(en)
*
|
2001-03-30 |
2007-04-10 |
Abbott Laboratories |
Hepatitis B virus surface antigen mutant and methods of detection thereof
|
EP1478751A4
(de)
|
2001-03-30 |
2005-10-19 |
Avigenics Inc |
Lysozym-promotor in vögeln
|
US7541512B2
(en)
*
|
2001-03-30 |
2009-06-02 |
Synageva Biopharma Corp. |
Avians containing a lysozyme promoter transgene
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
US20050031641A1
(en)
*
|
2001-04-06 |
2005-02-10 |
Loosmore Sheena May |
Recombinant vaccine against West Nile Virus
|
US7740863B2
(en)
*
|
2001-04-06 |
2010-06-22 |
Merial |
Recombinant vaccine against West Nile Virus
|
US20030148973A1
(en)
*
|
2001-05-23 |
2003-08-07 |
Peter Emtage |
MAGE-A1 peptides for treating or preventing cancer
|
US20030113919A1
(en)
*
|
2001-08-17 |
2003-06-19 |
Aventis Pasteur, Ltd. |
Immunogenic targets for melanoma
|
IL145397A0
(en)
*
|
2001-09-12 |
2002-06-30 |
Yissum Res Dev Co |
Compositions and methods for treatment of cancer
|
US7615209B2
(en)
|
2001-09-12 |
2009-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions of NDV and methods of use thereof for treatment of cancer
|
US7550650B2
(en)
*
|
2001-09-18 |
2009-06-23 |
Synageva Biopharma Corp. |
Production of a transgenic avian by cytoplasmic injection
|
WO2003085087A2
(en)
|
2002-04-09 |
2003-10-16 |
Aventis Pasteur, Limited |
Modified cea nucleic acid and expression vectors
|
WO2003043654A1
(fr)
*
|
2001-11-20 |
2003-05-30 |
Japan Science And Technology Agency |
Vaccin contre le virus de la vaccine de recombinaison
|
US7335761B2
(en)
*
|
2001-11-30 |
2008-02-26 |
Avigenics, Inc. |
Avian gene expression controlling regions
|
US20100333219A1
(en)
*
|
2001-11-30 |
2010-12-30 |
Synageva Biopharma Corp. |
Methods of protein production using ovomucoid regulatory regions
|
US6875588B2
(en)
|
2001-11-30 |
2005-04-05 |
Avigenics, Inc. |
Ovomucoid promoter and methods of use
|
US7294507B2
(en)
*
|
2001-11-30 |
2007-11-13 |
Avigenics, Inc. |
Ovomucoid promoters and methods of use
|
WO2003050268A2
(en)
*
|
2001-12-12 |
2003-06-19 |
Aventis Pasteur Limited |
Enhancement of the immune response using cd36-binding domain
|
US7135562B2
(en)
|
2002-03-14 |
2006-11-14 |
University Of Cincinnati |
Avian iFABP gene expression controlling region
|
US20040241723A1
(en)
*
|
2002-03-18 |
2004-12-02 |
Marquess Foley Leigh Shaw |
Systems and methods for improving protein and milk production of dairy herds
|
PT1350796E
(pt)
|
2002-04-05 |
2009-01-23 |
Merial Sas |
Bactérias gram-negativas atenuadas
|
SI1407033T1
(sl)
*
|
2002-05-16 |
2006-06-30 |
Bavarian Nordic As |
Intergenske regije kot insercijska mesta v genomumodificiranega virusavakcinije Ankara (MVA)
|
GB0215621D0
(en)
*
|
2002-07-05 |
2002-08-14 |
Imp College Innovations Ltd |
Improved poxvirus vaccines
|
DE60336653D1
(de)
*
|
2002-08-07 |
2011-05-19 |
Bavarian Nordic As |
Vaccinia virus wirtspektrum gene zur erhöhung des titers von avipoxviren
|
EP2269618A1
(de)
*
|
2002-08-12 |
2011-01-05 |
Jennerex Biotherapeutics ULC |
Ein onkolytisches Vaccinia-Virus zur Verwendung in Kombination mit Chemotherapie zur Behandlung von Krebs
|
NZ538575A
(en)
*
|
2002-09-05 |
2007-03-30 |
Bavarian Nordic As |
Method for the amplification of a virus wherein primary avian cells are cultivated in a serum-free medium comprising growth factors and attachment factors
|
EP1545575A4
(de)
|
2002-09-19 |
2006-04-05 |
Us Gov Health & Human Serv |
P. ariasi polypeptide, p. perniciosus polypeptide und anwendungsverfahren
|
AU2003281917A1
(en)
*
|
2002-09-23 |
2004-04-19 |
Mologen Ag |
Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats
|
MXPA05004714A
(es)
|
2002-10-29 |
2006-03-17 |
Us Gov Health & Human Serv |
Polipeptidos de lutzomyia longipalpis y metodos de uso.
|
EP1572985A4
(de)
*
|
2002-12-13 |
2008-03-19 |
Aventis Pasteur Inc |
Produktion von alvac auf embryonalenstammzellen von vögeln
|
CN1980571A
(zh)
*
|
2003-01-24 |
2007-06-13 |
阿维季尼克斯股份有限公司 |
禽类及禽蛋中表达的外源蛋白质
|
DE602004015418D1
(de)
*
|
2003-02-18 |
2008-09-11 |
Helmholtz Zentrum Muenchen |
Rekombinantes mva und verfahren zur erzeugung davon
|
EP1606419A1
(de)
|
2003-03-18 |
2005-12-21 |
Quantum Genetics Ireland Limited |
Systeme und methoden zur erhohung der milchproduktion in tieren
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
DE602004018927D1
(de)
|
2003-06-18 |
2009-02-26 |
Genelux Corp |
Modifizierte rekombinante vacciniaviren, verwendungen davon
|
JP4668919B2
(ja)
*
|
2003-10-08 |
2011-04-13 |
サノフィ パストゥール インコーポレイテッド |
修飾cea/b7ベクター
|
ES2417019T3
(es)
|
2003-11-13 |
2013-08-05 |
University Of Georgia Research Foundation, Inc. |
Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
|
ATE510928T1
(de)
|
2004-02-19 |
2011-06-15 |
Univ Alberta |
Leptinpromotor-polymorphismen und verwendungen davon
|
WO2005094185A2
(en)
*
|
2004-03-30 |
2005-10-13 |
Sudershan Biotech Limited |
Recombinant calf-chymosin and a process for producing the same
|
EP1773858B1
(de)
*
|
2004-05-27 |
2016-06-22 |
Janssen Biotech, Inc. |
Prostataspezifisches cynomolusantigen
|
DK1765387T3
(da)
*
|
2004-06-04 |
2013-03-04 |
Merial Ltd |
NÅLE-FRI ADMINISTRATION AF FeLV-VACCINER
|
EP1773406A4
(de)
*
|
2004-06-15 |
2008-09-03 |
Centocor Inc |
Verfahren zum screening von mitteln gegen erkrankung der menschlichen prostata
|
CA2571560C
(en)
*
|
2004-06-25 |
2016-04-12 |
Merial Limited |
Avipox recombinants expressing foot and mouth disease virus genes
|
CU23470A1
(es)
*
|
2004-08-11 |
2009-12-17 |
Ct Ingenieria Genetica Biotech |
Vectores vivos recombinantes y su uso en composiciones farmacéuticas contra el virus de la hepatitis c
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
MX2007010306A
(es)
*
|
2005-02-23 |
2007-09-26 |
Uab Research Foundation |
Vacunacion mejorada con alquil-glicosido.
|
WO2006113927A2
(en)
*
|
2005-04-20 |
2006-10-26 |
University Of Washington |
Immunogenic vaccinia peptides and methods of using same
|
US11865172B2
(en)
|
2005-04-21 |
2024-01-09 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
US7959929B2
(en)
|
2005-04-21 |
2011-06-14 |
University Of Florida Research Foundation, Inc. |
Materials and methods for respiratory disease control in canines
|
DK1881845T3
(da)
|
2005-04-25 |
2010-06-07 |
Merial Ltd |
Nipah-virusvacciner
|
ES2357679T3
(es)
|
2005-07-28 |
2011-04-28 |
Pfizer Products Inc. |
VACUNA CONTRA CALICIVIRUS FELINO (FCV) QUE COMPRENDE UNA PROTEINA DE CAPSIDA DE UN FCV O UNA PROTEINA DE LA CAPSIDA DE UN FCV AISLADA QUE COMPRENDE UNA SECUENCIA PROTEICA SEC ID Nº: 13 O SECUENCIAS PROTEICAS CON, AL MENOS, 95% DE IDENTIDAD CON ELLA.
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
KR20090004839A
(ko)
*
|
2005-09-07 |
2009-01-12 |
제네렉스, 인코포레이티드 |
Gm-csf를 발현하는 폭스바이러스를 사용한 전이성및/또는 전신 파종성 암의 전신 치료법
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
CA2629522A1
(en)
|
2005-11-14 |
2007-05-18 |
Merial Limited |
Gene therapy for renal failure
|
US7745158B2
(en)
*
|
2005-12-14 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Detection of secreted aspartyl proteases from Candida species
|
WO2007084568A2
(en)
|
2006-01-17 |
2007-07-26 |
Health Research, Inc. |
Heteroduplex tracking assay
|
JP2009531464A
(ja)
|
2006-03-29 |
2009-09-03 |
メリアル リミテッド |
連鎖球菌に対するワクチン
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
US20090060947A1
(en)
*
|
2006-05-19 |
2009-03-05 |
Sanofi Pasteur, Inc. |
Immunological compositions
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
CA2656266C
(en)
|
2006-06-20 |
2012-07-31 |
Transgene S.A. |
Recombinant viral vaccine
|
EP2415783B1
(de)
*
|
2006-10-16 |
2016-12-14 |
Genelux Corporation |
Modifizierte Impfstoffvirusstämme zur Verwendung in einem Diagnose- und Therapieverfahren
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
US7910112B2
(en)
*
|
2006-11-06 |
2011-03-22 |
Merial Limited |
Feline vaccines against avian influenza
|
US20080107687A1
(en)
*
|
2006-11-06 |
2008-05-08 |
Herve Poulet |
Feline vaccines against avian influenza
|
WO2008091311A1
(en)
*
|
2007-01-26 |
2008-07-31 |
Synageva Biopharma Corp |
Transgene expression in avians
|
RU2482189C2
(ru)
|
2007-01-30 |
2013-05-20 |
Трансген С.А. |
Полипептиды е2 папилломавируса, применяемые для вакцинации
|
KR20080084528A
(ko)
*
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
EP2171071B1
(de)
*
|
2007-06-15 |
2015-08-05 |
Genelux Corporation |
Für ein natriumabhängiges transporterprotein codierende vacciniavirus-vektoren zur bildlichen darstellung und/oder behandlung von tumoren
|
KR101542276B1
(ko)
*
|
2007-11-19 |
2015-08-06 |
트랜스진 에스.에이. |
폭스바이러스성 온콜리틱 벡터
|
RU2557312C2
(ru)
*
|
2007-11-19 |
2015-07-20 |
Трансжене С.А. |
Поксвирусные онколитические векторы
|
BRPI0908474A2
(pt)
|
2008-02-12 |
2016-07-26 |
Sanofi Pasteur Ltd |
métodos de uso de cromatografia de troca de íon e de filtração de gel para purificação de vírus causador da catapora
|
EA201591888A1
(ru)
|
2008-03-14 |
2016-05-31 |
Санофи Пастер Байолоджикс Ко. |
Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
|
EP2899203B1
(de)
*
|
2008-05-08 |
2019-07-10 |
Boehringer Ingelheim Animal Health USA Inc. |
Leishmania impfstoff unter verwendung von sandmücken speichelimmunogen
|
AU2009308331C1
(en)
*
|
2008-10-24 |
2015-07-09 |
Boehringer Ingelheim Animal Health USA Inc. |
Vaccine against African Horse Sickness Virus
|
CA2741650C
(en)
|
2008-10-27 |
2017-09-05 |
Qiagen Gaithersburg Inc. |
Fast results hybrid capture assay and system
|
ES2699685T3
(es)
|
2008-11-18 |
2019-02-12 |
Beth Israel Deaconess Medical Ct Inc |
Vacunas antivíricas con inmunogenicidad celular mejorada
|
EP3542815A1
(de)
|
2008-11-28 |
2019-09-25 |
Boehringer Ingelheim Animal Health USA Inc. |
Rekombinanter vogelgrippeimpfstoff und verwendungen davon
|
KR101741426B1
(ko)
|
2008-12-24 |
2017-05-30 |
더 킹덤 오드 더 네덜란드, 레프리젠티드 바이 더 미니스트리 오브 헬스, 웰페어 앤드 스포츠, 온 비하프 오브 더 미니스터, 더 내셔널 인스티튜트 포 퍼블릭 헬스 앤드 디 인바이런먼트 |
변형된 스트렙토코커스 뉴모니아 뉴몰리신(ply) 폴리펩타이드
|
EP2382474B1
(de)
|
2009-01-20 |
2015-03-04 |
Transgene SA |
Lösliches icam-1 als biomarker zur vorhersage einer therapeutischen antwort
|
US20100192236A1
(en)
*
|
2009-01-28 |
2010-07-29 |
University Of South Carolina |
Modulation of Delta Opioid Receptor Expression
|
SG2014014021A
(en)
|
2009-03-24 |
2014-07-30 |
Transgene Sa |
Biomarker for monitoring patients
|
EP2236520A1
(de)
*
|
2009-03-31 |
2010-10-06 |
Leukocare Ag |
Stabilisierungszusammensetzung für immobilisierte Biomoleküle
|
CN102428099B
(zh)
|
2009-04-03 |
2016-03-16 |
梅里亚有限公司 |
运载新城疫病毒的禽疫苗
|
NZ594896A
(en)
|
2009-04-17 |
2013-07-26 |
Transgene Sa |
Biomarker for monitoring patients
|
US20100284977A1
(en)
*
|
2009-04-28 |
2010-11-11 |
University Of South Carolina |
Expression of Anti-Nociceptive Compounds from Endogenously Regulated Promoters
|
WO2010127115A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Centre Hospitalier Universitaire Vaudois Lausanne (Chuv) |
Modified immunization vectors
|
CA2767458A1
(en)
|
2009-07-10 |
2011-01-13 |
Bruce Acres |
Biomarker for selecting patients and related methods
|
RU2016112465A
(ru)
|
2009-08-21 |
2018-11-27 |
Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. |
Рекомбинантная вакцина на основе парамиксовирусов птиц и способ её приготовления и применения
|
TWI627281B
(zh)
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
RU2555342C2
(ru)
|
2009-09-10 |
2015-07-10 |
Мериал Лимитед |
Новые вакцинные составы, включающие сапонинсодержащие адъюванты
|
BR112012005774B8
(pt)
|
2009-09-14 |
2023-02-14 |
Jennerex Inc |
uso de um inibidor de quinase antiangiogênico no tratamento de câncer
|
CA2777692A1
(en)
*
|
2009-10-14 |
2011-04-21 |
Sanjay Kapil |
Isolation of a virus related to canine parvovirus-2 from a raccoon
|
EP2491116A4
(de)
|
2009-10-22 |
2013-12-11 |
Univ Jefferson |
Zellbasierte antikrebszusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
|
AR079767A1
(es)
|
2009-12-28 |
2012-02-15 |
Merial Ltd |
Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo
|
US20130197612A1
(en)
|
2010-02-26 |
2013-08-01 |
Jack W. Lasersohn |
Electromagnetic Radiation Therapy
|
AU2011224188B2
(en)
|
2010-03-12 |
2015-01-22 |
Boehringer Ingelheim Animal Health USA Inc. |
Bluetongue virus recombinant vaccines and uses thereof
|
US9109007B2
(en)
|
2010-08-18 |
2015-08-18 |
Purdue Pharma L.P. |
MHC-I restricted epitopes containing non-natural amino acid residues
|
WO2012030720A1
(en)
|
2010-08-31 |
2012-03-08 |
Merial Limited |
Newcastle disease virus vectored herpesvirus vaccines
|
JP2013544504A
(ja)
|
2010-10-11 |
2013-12-19 |
ノバルティス アーゲー |
抗原送達プラットフォーム
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
CN103429258B
(zh)
|
2011-01-04 |
2016-03-09 |
新罗杰公司 |
通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
|
PL2667892T3
(pl)
|
2011-01-26 |
2019-09-30 |
Glaxosmithkline Biologicals Sa |
Schemat szczepień przeciwko rsv
|
WO2012101509A2
(en)
|
2011-01-28 |
2012-08-02 |
Sanofi Pasteur Sa |
Immunological compositions against hiv
|
EP3205353B1
(de)
|
2011-03-21 |
2021-01-13 |
Altimmune Inc. |
Schnell und lange wirkendes immunologisches therapeutikum
|
EP2694678A2
(de)
|
2011-04-04 |
2014-02-12 |
Netherland Cancer Institute |
Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung
|
US20140296248A1
(en)
|
2011-04-04 |
2014-10-02 |
Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis |
Methods and compositions for predicting resistance to anticancer treatment
|
DK2694101T3
(en)
|
2011-04-06 |
2017-01-09 |
Biovaxim Ltd |
Pharmaceutical compositions for the prevention and / or treatment of HIV disease in humans
|
ES2733211T3
(es)
|
2011-04-15 |
2019-11-28 |
Genelux Corp |
Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
|
WO2012145577A1
(en)
|
2011-04-20 |
2012-10-26 |
Merial Limited |
Adjuvanted rabies vaccine with improved viscosity profile
|
EP2701736A1
(de)
|
2011-04-25 |
2014-03-05 |
Advanced Bioscience Laboratories, Inc. |
Trunkierte hiv-hüllproteine (env), verfahren und zugehörige zusammensetzungen
|
MX361804B
(es)
|
2011-05-27 |
2018-12-17 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacunas genéticas contra el virus hendra y el virus nipah.
|
WO2012166493A1
(en)
|
2011-06-01 |
2012-12-06 |
Merial Limited |
Needle-free administration of prrsv vaccines
|
IN2014CN00547A
(de)
*
|
2011-07-20 |
2015-04-03 |
Merial Ltd |
|
US9717781B2
(en)
|
2011-08-08 |
2017-08-01 |
Alexander Shneider |
Methods and compositions relating to P62 for the treatment and prophylaxis of cancer
|
HUE035774T2
(en)
|
2011-08-12 |
2018-05-28 |
Merial Inc |
Biological substances, in particular vaccines, preserved by vacuum
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
WO2013033092A2
(en)
|
2011-09-03 |
2013-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Streptococcus suis pilus antigens
|
MX2014004214A
(es)
|
2011-10-11 |
2014-05-07 |
Novartis Ag |
Moleculas de acido ribonucleico policistronicas auto-replicantes recombinantes.
|
WO2013054199A2
(en)
|
2011-10-12 |
2013-04-18 |
Novartis Ag |
Cmv antigens and uses thereof
|
HRP20190525T8
(hr)
|
2011-11-30 |
2023-01-20 |
Boehringer Ingelheim Animal Health USA Inc. |
Rekombinantni vektori gallid herpesvirusa 3 (mdv serotip 2) koji eksprimiraju antigene ptičjih patogena i njihove uporabe
|
WO2013083753A2
(en)
|
2011-12-07 |
2013-06-13 |
Institut Pasteur |
Identification of a swine parecho-like virus and applications
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
WO2013106558A1
(en)
|
2012-01-10 |
2013-07-18 |
Merial Limited |
Lipid based adjuvants for dna - plasmid vaccines
|
CA2864119C
(en)
|
2012-02-14 |
2022-05-24 |
Merial Limited |
Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
|
WO2013138776A1
(en)
|
2012-03-16 |
2013-09-19 |
Merial Limited |
Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
|
ES2711878T3
(es)
|
2012-03-20 |
2019-05-08 |
Merial Inc |
Vacuna contra el virus del herpes equino 1 recombinante que contiene glicoproteína C mutada y usos de la misma
|
ES2664069T3
(es)
|
2012-06-13 |
2018-04-18 |
Merial, Inc. |
Vacunas contra BTV y AHSV de genoma reordenado
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
TWI638829B
(zh)
|
2012-07-10 |
2018-10-21 |
法商傳斯堅公司 |
分枝桿菌抗原疫苗
|
CA2879443A1
(en)
|
2012-07-19 |
2014-01-23 |
Zoetis Llc |
Bovine influenza virus compositions
|
AU2013295770A1
(en)
|
2012-07-27 |
2015-01-29 |
Zoetis Services Llc |
Tick toxin compositions
|
TWI690322B
(zh)
|
2012-10-02 |
2020-04-11 |
法商傳斯堅公司 |
含病毒的調配物及其使用
|
US20140140959A1
(en)
|
2012-10-05 |
2014-05-22 |
Aladar A. Szalay |
Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
|
AU2014203886B2
(en)
|
2013-01-07 |
2017-11-02 |
Beth Israel Deaconess Medical Center, Inc. |
Stabilized human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same
|
MX360137B
(es)
|
2013-02-21 |
2018-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
|
WO2014164697A1
(en)
|
2013-03-12 |
2014-10-09 |
Merial Limited |
Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
|
WO2014140938A2
(en)
|
2013-03-14 |
2014-09-18 |
Centre Hospitalier Universitaire Vaudois |
Immunological methods
|
WO2015048115A1
(en)
|
2013-09-25 |
2015-04-02 |
Zoetis Llc |
Pcv2b divergent vaccine composition and methods of use
|
US10716845B2
(en)
|
2013-10-04 |
2020-07-21 |
Beth Israel Deaconess Medical Center, Inc. |
Stabilized human immunodeficiency virus (HIV) clade C envelope (Env) trimer vaccines and methods of using same
|
MX2016004579A
(es)
|
2013-10-10 |
2016-12-09 |
Beth Israel Deaconess Medical Ct Inc |
Proteinas de union del miembro 1 de la familia de transmembrana 4 l-seis (tm4sf1) y metodos de uso de las mismas.
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
AU2014368898B2
(en)
|
2013-12-20 |
2020-06-11 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy with neoantigen vaccine
|
SG11201605316VA
(en)
|
2013-12-29 |
2016-07-28 |
Curelab Oncology Inc |
Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases
|
US10238700B2
(en)
|
2014-01-02 |
2019-03-26 |
Genelux Corporation |
Oncolytic virus adjunct therapy with agents that increase virus infectivity
|
US10765731B2
(en)
|
2014-01-09 |
2020-09-08 |
Transgene Sa |
Fusion of heterooligomeric mycobacterial antigens
|
EA201691993A1
(ru)
|
2014-04-03 |
2017-02-28 |
Бёрингер Ингельхайм Ветмедика, Инк. |
Вакцина к вирусу эпидемической диареи свиней
|
KR102457060B1
(ko)
*
|
2014-04-10 |
2022-10-19 |
트랜스진 |
폭스바이러스 종양용해 벡터
|
MX2017005687A
(es)
|
2014-11-03 |
2017-08-21 |
Merial Inc |
Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
|
EP3031822A1
(de)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus-Antigene
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
WO2016100977A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Methods for profiling the t-cel- receptor repertoire
|
EP3047856A1
(de)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv-antigene und ihre verwendungen
|
CN115300622A
(zh)
|
2015-02-25 |
2022-11-08 |
纪念斯隆-凯特琳癌症中心 |
使用灭活的修饰的痘苗病毒安卡拉作为实体肿瘤的单一免疫疗法或与免疫检查点阻断剂组合
|
JP6887955B2
(ja)
|
2015-03-18 |
2021-06-16 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. |
組換え体発現系のアッセイ
|
EP3283088A4
(de)
|
2015-04-17 |
2018-10-24 |
Memorial Sloan-Kettering Cancer Center |
Verwendung von mva oder mvadeltae3l als immunotherapeutika gegen solide tumoren
|
RU2733754C2
(ru)
|
2015-05-20 |
2020-10-06 |
Те Брод Инститьют Инк. |
Общие неоантигены
|
TWI750122B
(zh)
|
2015-06-09 |
2021-12-21 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
CA2990643C
(en)
|
2015-06-23 |
2023-10-17 |
Merial, Inc. |
Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
|
CA2995101A1
(en)
|
2015-08-14 |
2017-02-23 |
Zoetis Services Llc |
Mycoplasma bovis compositions
|
CA2996143A1
(en)
|
2015-08-20 |
2017-02-23 |
Merial, Inc. |
Fcv recombinant vaccines and uses thereof
|
CN108135993B
(zh)
|
2015-08-31 |
2022-03-22 |
贝林格尔·英格海姆维特梅迪卡有限公司 |
用于先天性震颤的瘟病毒疫苗
|
CA2996613A1
(en)
|
2015-09-16 |
2017-03-23 |
Boehringer Ingelheim Vetmedica, Inc. |
Salmonella choleraesuis-salmonella typhimurium vaccines
|
PL3355915T3
(pl)
|
2015-09-29 |
2024-03-25 |
Boehringer Ingelheim Animal Health USA Inc. |
Szczepionki zawierające cząstki wirusopodobne (VLP) parwowirusa psów (CPV) i ich zastosowania
|
US10780158B2
(en)
|
2015-11-16 |
2020-09-22 |
Georgia State University Research Foundation, Inc. |
Tunable vaccine platform against pathogens of the paramyxovirus family
|
RU2714428C2
(ru)
|
2015-11-23 |
2020-02-14 |
Мериал, Инк. |
Слитые белки fmdv-e2 и их применение
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
CA3015650A1
(en)
|
2016-02-25 |
2017-08-31 |
Memorial Sloan Kettering Cancer Center |
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human flt3l or gm-csf for cancer immunotherapy
|
JP7034080B2
(ja)
|
2016-02-25 |
2022-03-11 |
メモリアル スローン ケタリング キャンサー センター |
ヒトflt3lを発現する組換えmvaまたはmvaδe3lおよび固形腫瘍に対する免疫療法薬としてのそれらの使用
|
US20190346442A1
(en)
|
2016-04-18 |
2019-11-14 |
The Broad Institute, Inc. |
Improved hla epitope prediction
|
CA3023022A1
(en)
|
2016-05-04 |
2017-11-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
WO2017205674A1
(en)
|
2016-05-25 |
2017-11-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Oncolytic vaccinia virus mutants and using same for cancer treatment
|
JP7018941B2
(ja)
|
2016-06-17 |
2022-02-14 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
直鎖または分枝ポリアクリル酸ポリマーアジュバントを含む新規な免疫原性処方物
|
CA3031416C
(en)
*
|
2016-07-21 |
2023-09-19 |
Kolon Life Science, Inc. |
Recombinant vaccinia virus and use thereof
|
KR102566066B1
(ko)
|
2016-09-20 |
2023-08-16 |
베링거잉겔하임베트메디카게엠베하 |
신규한 돼지 인플루엔자 백신
|
TW201823467A
(zh)
|
2016-09-20 |
2018-07-01 |
德商百靈佳殷格翰維美迪加股份有限公司 |
犬腺病毒載體
|
UY37406A
(es)
|
2016-09-20 |
2018-03-23 |
Boehringer Ingelheim Vetmedica Gmbh |
Nuevo sitio de inserción orf70 de ehv
|
EA201990719A1
(ru)
|
2016-09-20 |
2019-10-31 |
|
Новые промоторы
|
WO2018069316A2
(en)
|
2016-10-10 |
2018-04-19 |
Transgene Sa |
Immunotherapeutic product and mdsc modulator combination therapy
|
US11230572B2
(en)
|
2016-10-17 |
2022-01-25 |
Beth Israel Deaconess Medical Center, Inc. |
Signature-based human immunodeficiency virus (HIV) envelope (Env) trimer vaccines and methods of using the same
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
US10660952B2
(en)
|
2016-11-03 |
2020-05-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
|
UA127859C2
(uk)
|
2016-11-03 |
2024-01-31 |
Бьорінгер Інгельхайм Ветмедіка Гмбх |
Вакцина проти свинячого парвовірусу
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
EP3573655A2
(de)
|
2017-01-30 |
2019-12-04 |
Boehringer Ingelheim Animal Health USA Inc. |
Impfstoffe gegen porzines coronavirus
|
WO2018209315A1
(en)
*
|
2017-05-12 |
2018-11-15 |
Memorial Sloan Kettering Cancer Center |
Vaccinia virus mutants useful for cancer immunotherapy
|
BR112020000711A2
(pt)
|
2017-07-12 |
2020-07-14 |
Boehringer Ingelheim Animal Health USA Inc. |
composições imunogênicas de senecavírus a e métodos destas
|
UY37889A
(es)
|
2017-09-23 |
2019-03-29 |
Boehringer Ingelheim Vetmedica Gmbh |
Sistema de expresión de paramyxoviridade, antígenos y composiciones inmunogénicas
|
WO2019092027A1
(en)
|
2017-11-09 |
2019-05-16 |
Boehringer Ingelheim Vetmedica Gmbh |
Sapelovirus immunogenic compositions and uses thereof
|
US10864263B2
(en)
|
2017-11-20 |
2020-12-15 |
Janssen Pharmaceuticals, Inc. |
Method of providing safe administration of adenoviral vectors encoding a zika virus antigen
|
WO2019134048A1
(en)
*
|
2018-01-05 |
2019-07-11 |
Bell John C |
Modified orthopoxvirus vectors
|
EA202091958A1
(ru)
|
2018-02-23 |
2021-02-04 |
Бёрингер Ингельхайм Ветмедика Гмбх |
Рекомбинантные вирусные векторные системы, экпрессирующие экзогенные гены кошачьего парамиксовируса, и вакцины, приготовленные из них
|
JP7245260B2
(ja)
|
2018-03-19 |
2023-03-23 |
ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー |
Ehv挿入部位ul43
|
US11384365B2
(en)
|
2018-03-19 |
2022-07-12 |
Boehringer Ingelheim Vetmedica Gmbh |
EHV with inactivated UL18 and/or UL8
|
US11957746B2
(en)
|
2018-03-26 |
2024-04-16 |
Boehringer Ingelheim Animal Health USA Inc. |
Method of producing an immunogenic composition
|
EP3773476A1
(de)
|
2018-03-30 |
2021-02-17 |
Arcturus Therapeutics, Inc. |
Lipidpartikel zur abgabe von nukleinsäuren
|
CN116162654A
(zh)
*
|
2018-09-15 |
2023-05-26 |
纪念斯隆凯特琳癌症中心 |
用于癌症免疫疗法的重组痘病毒
|
WO2020058341A1
(en)
|
2018-09-20 |
2020-03-26 |
Boehringer Ingelheim Vetmedica Gmbh |
Intranasal vector vaccine against porcine epidemic diarrhea
|
KR20210062015A
(ko)
|
2018-09-20 |
2021-05-28 |
베링거잉겔하임베트메디카게엠베하 |
변형된 pedv 스파이크 단백질
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
US20230201334A1
(en)
|
2019-07-24 |
2023-06-29 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
CN116096732A
(zh)
|
2020-01-31 |
2023-05-09 |
贝斯以色列护理医疗中心有限公司 |
用于预防和治疗冠状病毒感染的组合物和方法-sars-cov-2疫苗
|
WO2021158878A1
(en)
|
2020-02-06 |
2021-08-12 |
Boehringer Ingelheim Animal Health USA Inc. |
Polypeptides useful for detecting anti-rhabdovirus antibodies
|
CN116249774A
(zh)
|
2020-05-26 |
2023-06-09 |
迪奥尼斯治疗公司 |
核酸人工微型蛋白质组文库
|
JP2023544403A
(ja)
|
2020-10-05 |
2023-10-23 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
サーコウイルス科カプシドタンパク質を含む融合タンパク質、及びそれから構成されるキメラウイルス様粒子
|
CN116438195A
(zh)
|
2020-10-05 |
2023-07-14 |
勃林格殷格翰动物保健有限公司 |
用于针对轮状病毒疫苗接种的融合蛋白质
|
EP4384534A1
(de)
|
2021-08-11 |
2024-06-19 |
Sanofi Pasteur, Inc. |
Verkürzte influenza-neuraminidase und verfahren zur verwendung davon
|
EP4426829A1
(de)
|
2021-11-01 |
2024-09-11 |
Dana-Farber Cancer Institute, Inc. |
Biologisch ausgewählte bibliotheken künstlicher miniproteome von nukleinsäuren
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
WO2023194913A1
(en)
|
2022-04-05 |
2023-10-12 |
Boehringer Ingelheim Vetmedica Gmbh |
Immunogenic composition useful for vaccination against rotavirus
|
WO2023223255A1
(en)
|
2022-05-20 |
2023-11-23 |
Glaxosmithkline Biologicals Sa |
Modified varicella zoster virus glycoprotein e proteins
|
WO2024003353A1
(en)
|
2022-07-01 |
2024-01-04 |
Transgene |
Fusion protein comprising a surfactant-protein-d and a member of the tnfsf
|
WO2024011250A1
(en)
|
2022-07-08 |
2024-01-11 |
Viromissile, Inc. |
Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof
|
WO2024015892A1
(en)
|
2022-07-13 |
2024-01-18 |
The Broad Institute, Inc. |
Hla-ii immunopeptidome methods and systems for antigen discovery
|
CN116656730B
(zh)
*
|
2023-05-25 |
2024-03-19 |
军事科学院军事医学研究院军事兽医研究所 |
一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法
|